Vaneck Pharmaceutical Etf Price on September 7, 2023

PPH Etf  USD 89.03  0.95  1.06%   
Below is the normalized historical share price chart for VanEck Pharmaceutical ETF extending back to February 01, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of VanEck Pharmaceutical stands at 89.03, as last reported on the 11th of December 2024, with the highest price reaching 90.24 and the lowest price hitting 88.87 during the day.
3 y Volatility
14.04
200 Day MA
91.7222
1 y Volatility
12.51
50 Day MA
91.5182
Inception Date
2011-12-20
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in VanEck Etf, it is important to understand the factors that can impact its price. VanEck Pharmaceutical ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.2, which indicates the etf had a -0.2% return per unit of risk over the last 3 months. VanEck Pharmaceutical ETF exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VanEck Pharmaceutical's Coefficient Of Variation of (524.11), variance of 0.41, and Risk Adjusted Performance of (0.14) to confirm the risk estimate we provide.
  
VanEck Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2018

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPPH

Estimated Market Risk

 0.65
  actual daily
5
95% of assets are more volatile

Expected Return

 -0.13
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.2
  actual daily
0
Most of other assets perform better
Based on monthly moving average VanEck Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Pharmaceutical by adding VanEck Pharmaceutical to a well-diversified portfolio.
Average Mkt Cap Mil
134.3 K

VanEck Pharmaceutical Valuation on September 7, 2023

It is possible to determine the worth of VanEck Pharmaceutical on a given historical date. On September 7, 2023 VanEck was worth 78.69 at the beginning of the trading date compared to the closed value of 79.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of VanEck Pharmaceutical etf. Still, in general, we apply an absolute valuation method to find VanEck Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of VanEck Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against VanEck Pharmaceutical's related companies.
 Open High Low Close Volume
  79.20    79.20    78.24    78.52    122,638  
09/07/2023
  78.69    79.33    78.69    79.08    89,518  
  79.09    79.72    79.09    79.57    18,868  
Backtest VanEck Pharmaceutical  |  VanEck Pharmaceutical History  |  VanEck Pharmaceutical Valuation   PreviousNext  
Open Value
78.69
79.08
Closing Value
80.65
Upside

VanEck Pharmaceutical Trading Date Momentum on September 7, 2023

On September 08 2023 VanEck Pharmaceutical ETF was traded for  79.57  at the closing time. Highest VanEck Pharmaceutical's price during the trading hours was 79.72  and the lowest price during the day was  79.09 . The net volume was 18.9 K. The overall trading history on the 8th of September contributed to the next trading period price growth. The trading delta at closing time to the next next day price was 0.62% . The trading price change to current price is 1.10% .

VanEck Pharmaceutical ETF Fundamentals Correlations and Trends

By evaluating VanEck Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among VanEck Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. VanEck financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About VanEck Pharmaceutical Etf history

VanEck Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for VanEck is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in VanEck Pharmaceutical ETF will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing VanEck Pharmaceutical stock prices may prove useful in developing a viable investing in VanEck Pharmaceutical

VanEck Pharmaceutical Etf Technical Analysis

VanEck Pharmaceutical technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of VanEck Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of VanEck Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

VanEck Pharmaceutical Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

VanEck Pharmaceutical ETF cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

VanEck Pharmaceutical December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how VanEck Pharmaceutical etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VanEck Pharmaceutical shares will generate the highest return on investment. By undertsting and applying VanEck Pharmaceutical etf market strength indicators, traders can identify VanEck Pharmaceutical ETF entry and exit signals to maximize returns

VanEck Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for VanEck Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of VanEck Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of VanEck to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in VanEck Pharmaceutical ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.